Caplin Point Laboratories Competitors and Similar CompaniesClear all
Caplin Point Laboratories's competitors and similar companies include Alembic Pharmaceuticals, UCB, Cipla and EMS Pharma.
 Caplin Point Laboratories Caplin Point Laboratories is a pharmaceutical company manufacturing a range of formulations. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that manufactures branded formulations, international generics, and APIs (active pharmaceutical ingredients). |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Cipla Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases. |  EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | |
Founding Date | Founding Date 1990 | Founding Date 1907 | Founding Date 1928 | Founding Date 1935 | Founding Date 1964 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Chennai, IN HQ Chennai, IN Gerugambakkam, IN Suthukeny, IN | Locations Vadodara, IN HQ Mumbai, IN Vadodara, IN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Mumbai, IN HQ South Melbourne, AU Mumbai, IN Nairobi, KE Cape Town, ZA Durban, ZA Durban, ZA see more | Locations BR HQ |
Employees | Employees 3,40662% increase | Employees 14,858 | Employees 9,000 | Employees 27,764 | Employees 12,825 |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹16.8b (FY, 2024) | Revenue (est.) ₹61.1b (FY, 2024) | Revenue (est.) €4.9b (FY, 2023) | Revenue (est.) ₹254.5b (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods ₹7.2b (FY, 2024) | Cost of goods ₹19.3b (FY, 2024) | Cost of goods €1b (FY, 2023) | Cost of goods ₹88.2b (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit ₹9.8b (FY, 2024) | Gross profit ₹43b (FY, 2024) | Gross profit €4.8b (FY, 2023) | Gross profit ₹169.5b (FY, 2024) | Gross profit N/A |
Net income | Net income ₹4.6b (FY, 2024) | Net income ₹6.2b (FY, 2024) | Net income €343m (FY, 2023) | Net income ₹41.6b (FY, 2024) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Alembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that manufactures branded formulations, international generics, and APIs (active pharmaceutical ingredients).
View companyUCB
HQ
Brussels, BE
Employees
9,000
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyCipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases.
View companyEMS Pharma
HQ
BR
Employees
12,825
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View company